What is the recommended treatment for gastritis due to food allergies?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Treatment of Gastritis from Food Allergies

For gastritis caused by food allergies, strict elimination of the offending food allergen(s) from the diet is the primary treatment, combined with proton pump inhibitor (PPI) therapy twice daily for 8-12 weeks to manage gastric inflammation and promote mucosal healing.

Understanding the Condition

The question addresses gastritis specifically related to food allergies, which represents a form of eosinophilic gastroenteritis or allergic gastritis. This is distinct from typical gastritis and falls under the spectrum of gastrointestinal food allergies 1, 2, 3. These conditions result from adverse immune responses to dietary antigens causing inflammatory changes in the gastric mucosa.

Primary Treatment Approach

1. Food Allergen Elimination

Complete avoidance of identified food allergens is essential 4, 5, 6. This is the cornerstone of management for all food allergy-related gastrointestinal disorders.

  • Do not rely on allergy testing alone to guide elimination diets. Skin prick tests, specific IgE, and patch testing are not recommended for choosing dietary restrictions in eosinophilic gastrointestinal disorders 7.

  • Work with an experienced dietitian throughout the elimination and reintroduction process 7. This is strongly recommended to ensure nutritional adequacy and proper implementation.

  • Common food triggers include cow's milk, eggs, wheat, soy, peanuts/tree nuts, fish, and shellfish 1, 3.

2. Pharmacological Management

Proton Pump Inhibitors (First-Line Pharmacotherapy)

PPIs should be given twice daily for at least 8-12 weeks 7. They are effective in:

  • Inducing histological and clinical remission in eosinophilic gastrointestinal disorders 7
  • Reducing gastric acid and promoting mucosal healing 8
  • Maintaining remission once achieved 7

The evidence for PPIs in eosinophilic conditions is moderate quality with strong recommendations 7.

Topical Steroids (Alternative or Adjunctive)

If PPIs are insufficient or for esophageal involvement:

  • Topical steroids are highly effective for inducing histological and clinical remission 7 (High-grade evidence)
  • Maintenance treatment is typically required as relapse rates are high after withdrawal 7

Mucoprotective Agents

For gastric mucosal protection, consider agents that:

  • Promote mucosal regeneration
  • Reduce inflammation
  • Mitigate oxidative stress 8

Treatment Algorithm

Step 1: Identify suspected food allergen(s) through detailed clinical history of reproducible symptoms after specific food ingestion 1, 6

Step 2: Initiate strict elimination diet of suspected allergen(s) with dietitian support 7

Step 3: Start PPI therapy twice daily for 8-12 weeks 7

Step 4: Assess response at 8-12 weeks with endoscopy and biopsy if symptoms persist 7 (symptoms may not correlate with histological activity)

Step 5: If inadequate response:

  • Consider topical steroids 7
  • Expand elimination diet (e.g., from 2-food to 4-food or 6-food elimination) 7
  • Combination therapy may be considered in refractory cases 7

Important Caveats

Avoid these approaches:

  • Sodium cromoglycate, montelukast, and antihistamines are NOT effective for eosinophilic gastrointestinal disorders 7 (though they may help concomitant atopic disease)
  • Immunomodulators (azathioprine, 6-mercaptopurine) are not recommended 7
  • Standard IBD biologics (anti-TNF, anti-integrin) are not recommended 7

Common pitfalls:

  • Relying solely on allergy testing to guide food elimination—this has the lowest remission rates 7
  • Stopping treatment prematurely—maintain PPI or steroid therapy as relapse is common 7
  • Not involving a dietitian—nutritional deficiencies and growth deficits can occur with elimination diets 4

Monitoring and Follow-up

  • Repeat endoscopy with biopsy if symptoms recur during treatment 7 to assess for refractory disease, strictures, or treatment complications
  • Histological remission (not just symptom improvement) should be the treatment goal 7
  • For refractory cases with significant atopic disease, joint management with a gastroenterologist and allergist is recommended 7

Emerging Therapies

Novel biologics (dupilumab, cendakimab, benralizumab) show promise for eosinophilic gastrointestinal disorders 7, 9, but are currently reserved for refractory cases or those with coexisting severe allergic conditions.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.